CAR-T Cell Therapy for Solid Tumors
Revolutionary CAR-T cell therapy targeting solid tumors including lung, breast, and gastrointestinal cancers. This cutting-edge treatment genetically modifies your own immune cells to fight cancer.
Trial Overview
This Phase 2 clinical trial evaluates the safety and effectiveness of CAR-T cell therapy in patients with advanced solid tumors. CAR-T therapy has shown remarkable success in blood cancers and is now being adapted for solid tumors.
The treatment involves collecting your T cells, genetically engineering them to recognize cancer cells, and then infusing them back to attack the tumor. This personalized approach offers new hope for patients with limited treatment options.
Key Benefits
- • Personalized cancer treatment
- • Potential for long-term remission
- • Targets multiple solid tumor types
- • Advanced immunotherapy approach
Trial Details
Eligibility
- • Adults 18+ with advanced solid tumors
- • Failed standard treatments
- • Good overall health status
- • No active infections
Treatment Process
Cell Collection
T cells are collected from your blood through a process called leukapheresis
Genetic Engineering
T cells are modified in the lab to express CAR receptors that target cancer
Cell Expansion
Modified CAR-T cells are grown to create millions of cancer-fighting cells
Infusion
CAR-T cells are infused back into your body to attack the cancer
Target Cancer Types
Lung Cancer
Non-small cell and small cell lung cancer, including advanced stages
- • Adenocarcinoma
- • Squamous cell carcinoma
- • Large cell carcinoma
Breast Cancer
Triple-negative and HER2-negative breast cancer subtypes
- • Triple-negative
- • HER2-negative
- • Hormone receptor negative
GI Cancers
Gastrointestinal cancers including stomach, colon, and pancreatic
- • Gastric cancer
- • Colorectal cancer
- • Pancreatic cancer
Safety & Monitoring
Safety Measures
- • Comprehensive pre-treatment screening
- • Inpatient monitoring during infusion
- • 24/7 medical support available
- • Regular follow-up appointments
- • Emergency response protocols
Monitoring Schedule
- • Daily monitoring for first week
- • Weekly visits for first month
- • Monthly visits for first year
- • Quarterly visits thereafter
- • Long-term follow-up care
Ready to Join This Trial?
This innovative CAR-T therapy could offer new hope for your cancer treatment. Join the fight against solid tumors with cutting-edge immunotherapy.